Abstract:In this research, we analyzed the relationship between gut microbiota and tumor. We discovered that both subcutaneous and metastatic tumors would alter the composition and metabolic function of gut microbiota. Meanwhile, fecal microbiota transplantation also indicated the anti‐tumor role of the gut microbiota, revealing the crosstalk between tumor and gut microbiota. Gut microbiota has a proven link with the development and treatment of cancer. However, the causality between gut microbiota and cancer development is still unknown and deserves exploration. In this study, we aimed to explore the alterations in gut microbiota in murine tumor models and the crosstalk between the tumor and the gut microbiota. The subcutaneous and intravenous murine tumor models using both the colorectal cancer cell line MC38 and lung cancer cell line LLC were constructed. Then fecal samples before and after tumor inoculation were collected for whole metagenomics sequencing. Both subcutaneous and metastatic tumors markedly elevated the α‐diversity of the gut microbiota. Relative abundance of Ligilactobacillus and Lactobacillus was reduced after subcutaneously inoculating tumor cells, whereas Bacteroides and Duncaniella were reduced in metastatic tumors, regardless of tumor type. At the species level, Lachnospiraceae bacterium was enriched after both subcutaneous and intravenous tumors inoculation, whereas levels of Muribaculaceae bacterium Isolate‐110 (HZI), Ligilactobacillus murinus and Bacteroides acidifaciens reduced. Metabolic function analysis showed that the reductive pentose phosphate cycle, urea cycle, ketone body biosynthesis, ectoine biosynthesis, C4‐dicarboxylic acid cycle, isoleucine biosynthesis, inosine 5′‐monophosphate (IMP), and uridine 5′‐monophosphate (UMP) biosynthesis were elevated after tumor inoculation, whereas the cofactor and vitamin biosynthesis were deficient. Principal coordinates analysis (PCoA) showed that subcutaneous and metastatic tumors partially shared the same effect patterns on gut microbiota. Furthermore, fecal microbiota transplantation revealed that this altered microbiota could influence tumor growth. Taken together, this study demonstrated that both colorectal cancer (MC38) and non‐colorectal cancer (LLC) can cause gut dysbiosis and metabolic imbalance, regardless of tumor type and process of tumor inoculation, and this dysbiosis influenced the tumor growth. This research gives novel insights into the crosstalk between tumors and the gut microbiota.

Influence of gut microbiota on the development of tumor via the gut-brain axis

Gut microbiota influence tumor development and Alter interactions with the human immune system

Gut Microbiota in Brain Tumors: an Emerging Crucial Player.

Relating Gut Microbiome and Its Modulating Factors to Immunotherapy in Solid Tumors: A Systematic Review

Influence of gut microecology in the development of malignant tumors and its potential therapeutic application: A review

Crosstalk between gut microbiota and tumor: tumors could cause gut dysbiosis and metabolic imbalance

Advances in the role of gut microbiota in the regulation of the tumor microenvironment (Review)

The crosstalk between the gut microbiota and tumor immunity: Implications for cancer progression and treatment outcomes

Gut Microbiota-Mediated Modulation of Cancer Progression and Therapy Efficacy

Influence of the gut microbiota on immune cell interactions and cancer treatment

Effects of Gut Microbiota on Host Adaptive Immunity Under Immune Homeostasis and Tumor Pathology State

Gut microbiota-mediated immunomodulation in tumor

The impact of the gut microbiome on tumor immunotherapy: from mechanism to application strategies

Gut Microbiota and Tumor Immune Escape: A New Perspective for Improving Tumor Immunotherapy

The role of the gut microbiota and probiotics associated with microbial metabolisms in cancer prevention and therapy

Gut microbiota and its therapeutic implications in tumor microenvironment interactions

Microbial influence on triggering and treatment of host cancer: An intestinal barrier perspective

Microbiota in tumors: new factor influencing cancer development

Exploring the Emerging Role of the Gut Microbiota and Tumor Microenvironment in Cancer Immunotherapy

The Emerging Roles of Human Gut Microbiota in Gastrointestinal Cancer

Beyond the Gut: The intratumoral microbiome's influence on tumorigenesis and treatment response.